A novel telomerase-based approach to detect natural cell-mediated cytotoxic activity against tumor cells in vitro

Journal of Immunological Methods

Volumn 305, Issue 2, 2005, Pages 162-172

  Faraoni, Isabella ^a   Cottarelli, Andrea ^a   Giuliani, Anna ^a   Bonmassar, Laura ^b   Rossi, Lorena ^a   Bonmassar, Enzo ^a,b  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Cytolysis; Cytotoxicity assay; LAK; Natural immunity; NK; Telomerase

Indexed keywords

CHROMIUM 51; GAMMA INTERFERON; TELOMERASE;

ARTICLE; CANCER CELL; CELL MEDIATED CYTOTOXICITY; COCULTURE; CONTROLLED STUDY; CYTOLYSIS; EFFECTOR CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSPOT ASSAY; ERYTHROLEUKEMIA CELL; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; RAJI CELL; TARGET CELL; TUMOR BIOPSY; TUMOR CELL; TUMOR DIAGNOSIS;

CHROMIUM RADIOISOTOPES; CYTOTOXICITY TESTS, IMMUNOLOGIC; HUMANS; K562 CELLS; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TELOMERASE;

EID: 26244462631     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.07.015     Document Type: Article

References (39)

1. M. Akiyama, J. Horiguchi-Yamada, S. Saito, Y. Hoshi, O. Yamada, H. Mizoguchi, and H. Yamada Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro Eur. J. Cancer 35 1999 309
2. M. Akiyama, O. Yamada, T. Hideshima, T. Yanagisawa, K. Yokoi, K. Fujisawa, Y. Eto, H. Yamada, and K.C. Anderson TNFalpha induces rapid activation and nuclear translocation of telomerase in human lymphocytes Biochem. Biophys. Res. Commun. 316 2004 528
3. R.C. Allsopp, H. Vaziri, C. Patterson, S. Goldstein, E.V. Younglai, A.B. Futcher, C.W. Greider, and C.B. Harley Telomere length predicts replicative capacity of human fibroblasts Proc. Natl. Acad. Sci. U. S. A. 89 1992 10114
4. S.W. Braun, H.H. Gerhartz, and H.M. Schmetzer Influence of cytokines and autologous lymphokine-activated killer cells on leukemic bone marrow cells and colonies in AML Acta Haematol. 105 2001 209
5. D. Broccoli, J.W. Young, and T. de Lange Telomerase activity in normal and malignant hematopoietic cells Proc. Natl. Acad. Sci. U. S. A. 92 1995 9082
6. T.M. Bryan, and T.R. Cech Telomerase and maintenance of chromosome ends Curr. Opin. Cell Biol. 11 1999 318
7. T.M. Bryan, A. Englezou, I. Dalla-Pozza, M. Dunham, and R.R. Reddel Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines Nat. Med. 3 1997 1271
8. M.A. Cerone, J.A. Londono-Vallejo, and S. Bacchetti Telomere maintenance by telomerase and by recombination can coexist in human cells Hum. Mol. Genet. 10 2001 1945
9. F.E. Davies, N. Raje, T. Hideshima, S. Lentzsch, G. Young, Y.T. Tai, B. Lin, K. Podar, D. Gupta, D. Chauhan, S.P. Treon, P.G. Richardson, R.L. Schlossman, G.J. Morgan, G.W. Muller, D.I. Stirling, and K.C. Anderson Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma Blood 98 2001 210
10. S.S. Farag, T.A. Fehniger, B. Becknell, B.W. Blaser, and M.A. Caligiuri New directions in natural killer cell-based immunotherapy of human cancer Expert Opin. Biol. Ther. 3 2003 237
11. Faraoni, I., Bonmassar, E., 2002. Telomerase activity as a marker of tumor cell survival to evaluate sensitivity of neoplastic cells to cancer treatment. In: Krupp, G., Parwaresch, R. (Eds.). Telomerases, telomeres and cancer. Landes Bioscience/Eurekah.com and Kluwer Academic/Plenum Publishers, 84.
12. I. Faraoni, M. Turriziani, G. Masci, L. De Vecchis, J.W. Shay, E. Bonmassar, and G. Graziani Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro Clin. Cancer Res. 3 1997 579
13. I. Faraoni, G. Graziani, M. Turriziani, G. Masci, M. Mezzetti, A. Testori, U. Veronesi, and E. Bonmassar Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: in vitro studies with fresh human tumor samples Lab. Invest. 79 1999 993
14. O. Franzese, A. Lombardi, A. Comandini, E. Cannavò, C. Testorelli, I. Cirello, and E. Bonmassar Effect of Saquinavir on proliferation and telomerase activity of human peripheral blood mononuclear cells Life Sci. 69 2001 1509
15. R. Gonzalez-Quevedo, C. de Juan, M.J. Massa, A. Sanchez-Pernaute, A. Torres, J.L. Balibrea, M. Benito, and P. Iniesta Detection of telomerase activity in human carcinomas using a trap-ELISA method: correlation with hTR and hTERT expression Int. J. Oncol. 16 2000 623
16. R.L. Hayes, E. Arbit, M. Odaimi, S. Pannullo, R. Scheff, D. Kravchinskiy, and C. Zaroulis Adoptive cellular immunotherapy for the treatment of malignant gliomas Crit. Rev. Oncol. Hematol. 39 2001 31
17. J.A. Heibein, I.S. Goping, M. Barry, M.J. Pinkoski, G.C. Shore, D.R. Green, and R.C. Bleackley Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax J. Exp. Med. 192 2000 1391
18. J.L. Hess, and W.E. Highsmith Telomerase detection in body fluids Clin. Chem. 48 2002 18
19. W. Jennes, L. Kestens, D.F. Nixon, and B.L. Shacklett Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15-the Amlispot assay J. Immunol. Methods 270 2002 99
20. N.W. Kim, M.A. Piatyszek, K.R. Prowse, C.B. Harley, M.D. West, P.L. Ho, G.M. Coviello, W.E. Wright, S.L. Weinrich, and J.W. Shay Specific association of human telomerase activity with immortal cell and cancer Science 266 1994 2011
21. S.W. Krause, R. Gastpar, R. Andreesen, C. Gross, H. Ullrich, G. Thonigs, K. Pfister, and G. Multhoff Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase I trial Clin. Cancer Res. 10 2004 3699
22. S.H. Lee, J.W. Kim, H.W. Lee, Y.S. Cho, S.H. Oh, Y.J. Kim, C.H. Jung, W. Zhan, and J.H. Lee Interferon regulatory factor-1 (IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression Oncogene 22 2003 381
23. K. Liu, R.J. Hodes, and N.P. Weng Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation J. Immunol. 166 2001 4826
24. F. Lozupone, D. Pende, V.L. Burgio, C. Castelli, M. Spada, M. Venditti, F. Luciani, L. Luigini, C. Federici, C. Ramoni, L. Rivoltini, G. Parmiani, F. Belardelli, P. Rivera, S. Marcenaro, L. Moretta, and S. Fais Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice Cancer Res. 64 2004 378
25. G. Maki Ex vivo purging of stem cell autografts using cytotoxic cells J. Hematother. Stem Cell Res. 10 2001 545
26. R.S. Maser, and R.A. DePinho Connecting chromosomes, crisis and cancer Science 297 2002 565
27. H. Mese, Y. Ueyama, A. Suzuki, S. Nakayama, A. Sasaki, H. Hamakawa, and T. Matsumura Inhibition of telomerase activity as a measure of tumor cell killing by cisplatin in squamous cell carcinoma cell line Chemotherapy 47 2001 136
28. G.B. Morin The human telomere terminal trasnferase enzyme is a ribonucloprotein that synthesizes TTAGGG repeats Cell 59 1989 521
29. M. Papamichail, S.A. Perez, A.D. Gritzapis, and C.N. Baxevanis Natural killer lymphocytes: biology, development, and function Cancer Immunol. Immunother. 53 2004 176
30. K.H. Park, S.Y. Rha, C.H. Kim, T.S. Kim, N.C. Yoo, J.H. Kim, J.K. Roh, J.S. Noh Min, K.S. Lee, B.S. Kim, and H.C. Chung Telomerase activity and telomere lengths in various cell lines: changes of telomerase activity can be another method for chemosensitivity evaluation Int. J. Oncol. 13 1998 489
31. C.D. Platsoucas, J.E. Fincke, J. Pappas, W.J. Jung, M. Heckel, R. Schwarting, E. Magira, D. Monos, and R.S. Freedman Immune responses to human tumors: development of tumor vaccines Anticancer Res. 23 2003 1969
32. A. Stift, M. Sachet, R. Yagubian, C. Bittermann, P. Dubsky, C. Brostjan, R. Pfragner, B. Niederle, R. Jakesz, M. Gnan, and J. Fiedl Dendritic cell vaccination in medullary thyroid carcinoma Clin. Cancer Res. 10 2004 2944
33. J.A. Trapani, and M.J. Smyth Functional significance of the perforin/granzyme cell death pathway Nat. Rev., Immunol. 2 2002 735
34. D. Valteau-Couanet, C. Leboulaire, K. Maincent, M. Tournier, O. Hartmann, J. Bénard, F. Beaujean, C. Boccaccio, L. Zitvogel, and E. Angevin Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients Blood 100 2002 2554
35. F.S. Wang, M.X. Liu, B. Zhang, M. Shi, Z.Y. Lei, W.B. Sun, Q.Y. Du, and J.M. Chen Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo World J. Gastroenterol. 8 2002 464
36. N. Weng, B.L. Levine, C.H. June, and R.J. Hodes Regulated expression of telomerase activity in human T lymphocyte development and activation J. Exp. Med. 183 1996 2471
37. W.E. Wright, J.W. Shay, and M.A. Piatyszek Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity Nucleic Acids Res. 23 1995 3794
38. W.E. Wright, M.A. Piatyszek, W.E. Rainey, W. Byrd, and J.W. Shay Telomerase activity in human germline and embryonic tissue and cells Dev. Genet. 18 1996 173
39. J. Wu, and L.L. Lanier Natural killer cells and cancer Adv. Cancer Res. 90 2003 127